1. NUTRITION FOR ARMD AUTUMN 2015

2. MACULAR DEGENERATION WETDRY

3. MACULAR DEGENERATION RISK FACTORS AGE AGE FAMILY HISTORY FAMILY HISTORY FEMALE (CHILDBIRTH AND LACK OF OESTROGEN USE) FEMALE (CHILDBIRTH AND LACK OF OESTROGEN USE) LIGHT COLOURED IRISES LIGHT COLOURED IRISES LONG SIGHTEDNESS LONG SIGHTEDNESS SMOKING SMOKING LIFETIME SUNLIGHT EXPOSURE LIFETIME SUNLIGHT EXPOSURE EXCESS ALCOHOL EXCESS ALCOHOL TOTAL CHOLESTEROL TOTAL CHOLESTEROL LOW SERUM ZINC LOW SERUM ZINC LOW CAROTENOIDS INTAKE LOW CAROTENOIDS INTAKE HYPERTENSION HYPERTENSION CARDIOVASCULAR DISEASE CARDIOVASCULAR DISEASE

4. SELECTED MACULAR DEGENERATION RESEARCH RESULTS 1988 NEWSOME - ZINC 1988 NEWSOME - ZINC NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY - VITAMIN A AND C NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY - VITAMIN A AND C 1993- 2003 BEAVER DAM STUDY - LYCOPENE > LUTEIN & ZEAXANTHIN 1993- 2003 BEAVER DAM STUDY - LYCOPENE > LUTEIN & ZEAXANTHIN EYE DISEASE CASE CONTROL STUDY –LUTEIN > ZEAXANTHIN > BETA-CAROTENE > ALPHA-CAROTENE > CRYPTOXANTHIN, BUT NOT LYCOPENE EYE DISEASE CASE CONTROL STUDY –LUTEIN > ZEAXANTHIN > BETA-CAROTENE > ALPHA-CAROTENE > CRYPTOXANTHIN, BUT NOT LYCOPENE AGE RELATED EYE DISEASE STUDY :- AGE RELATED EYE DISEASE STUDY :-

5. AGE-RELATED EYE DISEASE STUDY OCTOBER 2001 - 11 CENTRES, 3557 PARTICIPANTS OCTOBER 2001 - 11 CENTRES, 3557 PARTICIPANTS AGED 55-80, REPORT NO.8 - ARMD AGED 55-80, REPORT NO.8 - ARMD STUDIED BI-ANNUALLY FOR 6.3 YEARS STUDIED BI-ANNUALLY FOR 6.3 YEARS DIVIDED INTO 4 GROUPS DIVIDED INTO 4 GROUPS A) ANTIOXIDANTS (VITS C, E AND BETA-CAROTENE) B) ZINC (ZINC OXIDE AND CUPRIC OXIDE) C) ANTIOXIDANTS AND ZINC D) PLACEBO

6. AREDS 1 RESULTS A) 17% REDUCTION IN DISEASE PROGRESSION 10% REDUCTION IN VISUAL LOSS 10% REDUCTION IN VISUAL LOSS B) 21% REDUCTION IN DISEASE PROGRESSION 11% REDUCTION IN VISUAL LOSS 11% REDUCTION IN VISUAL LOSS C) 25% REDUCTION IN DISEASE PROGRESSION 19% REDUCTION IN VISUAL LOSS 19% REDUCTION IN VISUAL LOSS

7. AREDS 2 RESULTS AREDS 2 - LUTEIN AND ZEAXANTHIN ADDED TO ANTIOXIDANTS AND ZINC (WITH COPPER) AREDS 2 - LUTEIN AND ZEAXANTHIN ADDED TO ANTIOXIDANTS AND ZINC (WITH COPPER) BETA-CAROTENE EXCLUDED BECAUSE OF RISKS BETA-CAROTENE EXCLUDED BECAUSE OF RISKS RESULTS NOWHERE NEAR AS CONCLUSIVE AS AREDS1 AS TO INCREASED BENEFITS RESULTS NOWHERE NEAR AS CONCLUSIVE AS AREDS1 AS TO INCREASED BENEFITS LUTEIN IS AN EXPENSIVE SUPPLEMENT LUTEIN IS AN EXPENSIVE SUPPLEMENT SOME DEBATE AS TO WHETHER ZEAXANTHIN CAN BE ABSORBED BY HUMANS OR WHETHER LUTEIN IS CONVERTED IN THE BODY SOME DEBATE AS TO WHETHER ZEAXANTHIN CAN BE ABSORBED BY HUMANS OR WHETHER LUTEIN IS CONVERTED IN THE BODY MESO-XEATHANTHIN IS THOUGHT TO BE THE IMPORTANT FORM OF ZEAXANTHIN MESO-XEATHANTHIN IS THOUGHT TO BE THE IMPORTANT FORM OF ZEAXANTHIN NOW AWAITING CARREDS RESEARCH RESULTS NOW AWAITING CARREDS RESEARCH RESULTS

8. THE BIG FIVE – ADVICE FOR “ARMD” PATIENTS WEAR U.V. AND BLUE LIGHT PROTECTIVE LENSES (MORE THAN UV400) WEAR U.V. AND BLUE LIGHT PROTECTIVE LENSES (MORE THAN UV400) ALTER DIET TO CONTAIN GREEN LEAFY VEGETABLES, CARROTS AND CORN (RAINBOW DIET) ALTER DIET TO CONTAIN GREEN LEAFY VEGETABLES, CARROTS AND CORN (RAINBOW DIET) TAKE SLOW RELEASE VITAMIN AND MINERAL SUPPLEMENTS WITH A MEAL TAKE SLOW RELEASE VITAMIN AND MINERAL SUPPLEMENTS WITH A MEAL CONSULT G.P. FOR TREATMENT OF HYPERTENSION AND HYPERCHOLESTEROLAEMIA CONSULT G.P. FOR TREATMENT OF HYPERTENSION AND HYPERCHOLESTEROLAEMIA STOP SMOKING STOP SMOKING